WHALE.TIPS CONTENT

Tuesday, December 21, 2021 20:12:17 UTC

NOVAVAX INC: We entered a call option, $180.00 strike price, at 11:13 AM with a limit buy. We exited 3 hours later by limit sale for a 100% profit!

Cleared final positions after Joe Biden Spoke.(More)

@novavax @novavax @moderna_tx

#nvax #bntx #pfe #mrna #novavaxinc #nvax #novavaxinc #covid #vaccine #pfizer #who #biontech

RELATED:

Tue, Dec 28, 21
NVAX: Novavax Inc

Thu, Dec 23, 21
NVAX: Novavax Inc

Sat, Dec 4, 21
PFE: Pfizer Inc

NVAX

Novavax Inc
Thu, Aug 11, 22 7:00 PM UTC
Price: $40.83
Volume 76766
Thu, Aug 11, 22 (EOD)
Price: $40.34
Volume 6583070
RELATED:

Tue, Dec 28, 21
NVAX: Novavax Inc

Thu, Dec 23, 21
NVAX: Novavax Inc

Sat, Dec 4, 21
PFE: Pfizer Inc

NVAX

Novavax Inc
Thu, Aug 11, 22 7:00 PM UTC
Price: $40.83
Volume 76766
Thu, Aug 11, 22 (EOD)
Price: $40.34
Volume 6583070

Monday, December 20, 2021 12:57:10 UTC

With an emergency approval for use by the WHO, Novavax is ripping in premarket, and options have been historically adjusting very well for this stock.

The stock increased after World Health Organization granted the vaccine company and the Serum Institute of India an emergency use authorization for their Covid-19 vaccine.

Covovax, which is manufactured and marketed by the Serum Institute for India and other developing nations, has been awarded emergency use status by the WHO.

Novavax's Covid-19 vaccine is protein-based, unlike the vaccines developed by the Pfizer (PFE) and BioNTech (BNTX) alliance and Moderna (MRNA), which are based on messenger RNA drug technology.

NOTE: This is not an endorsement or rejection of vaccines. This is a stock market news item.(More)

NOVAVAX APPROVED FOR EMERGENCY USE

Monday, December 20, 2021 12:57:10 UTC

With an emergency approval for use by the WHO, Novavax is ripping in premarket, and options have been historically adjusting very well for this stock.

The stock increased after World Health Organization granted the vaccine company and the Serum Institute of India an emergency use authorization for their Covid-19 vaccine.

Covovax, which is manufactured and marketed by the Serum Institute for India and other developing nations, has been awarded emergency use status by the WHO.

Novavax's Covid-19 vaccine is protein-based, unlike the vaccines developed by the Pfizer (PFE) and BioNTech (BNTX) alliance and Moderna (MRNA), which are based on messenger RNA drug technology.

NOTE: This is not an endorsement or rejection of vaccines. This is a stock market news item.

#nvax #novavaxinc #covid #vaccine #pfizer #who #biontech


Friday, December 10, 2021 18:58:49 UTC

COSTCO WHOLESALE CORP: We entered a call option, $540.00 strike price, at 9:30 AM with a limit buy. We exited 4 hours later by limit sale for a 386% profit!

* * * Play of the day! * * * Play of the Week * * * All remaining positions sold.(More)

COST: COSTCO WHOLESALE CORP

Friday, December 10, 2021 18:58:49 UTC

COSTCO WHOLESALE CORP: We entered a call option, $540.00 strike price, at 9:30 AM with a limit buy. We exited 4 hours later by limit sale for a 386% profit!

* * * Play of the day! * * * Play of the Week * * * All remaining positions sold.

#playoftheday #playoftheweek #costco #wallmart #amazon